The present invention relates to the effects of Physalis minima L. methanolic extract on dyslipidemia and insulin resistance in insulin resistant high-fat diet-induced obese rats without any systemic toxicities. The extract reversed the dyslipidemia and insulin resistance in high-fat diet-induced obese rats.